HomeCERS • NASDAQ
add
Cerus Corp
Previous close
$1.67
Day range
$1.66 - $1.82
Year range
$1.38 - $2.59
Market cap
332.43M USD
Avg Volume
1.94M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 46.02M | 15.70% |
Operating expense | 27.16M | 6.68% |
Net income | -2.93M | 59.63% |
Net profit margin | -6.38 | 65.08% |
Earnings per share | -0.02 | 33.33% |
EBITDA | -549.00K | 81.49% |
Effective tax rate | -2.66% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 75.56M | -4.36% |
Total assets | 189.54M | -7.92% |
Total liabilities | 135.26M | -13.75% |
Total equity | 54.28M | — |
Shares outstanding | 185.72M | — |
Price to book | 5.76 | — |
Return on assets | -1.28% | — |
Return on capital | -1.60% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -2.93M | 59.63% |
Cash from operations | 4.07M | 138.80% |
Cash from investing | 4.82M | 1,851.64% |
Cash from financing | 60.00K | -99.21% |
Net change in cash | 9.10M | 378.34% |
Free cash flow | -2.85M | 66.42% |
About
Cerus Corporation is an American multinational biotechnology company headquartered in Concord, California that develops and provides a treatment system to pathogen-reduce human blood products for the healthcare industry. Wikipedia
Founded
Sep 1991
Headquarters
Website
Employees
631
